This inventor holds 3 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1995-1998.
Company Filing History:
Years Active: 1995-1998
Title: The Innovations of Jose Van Der Heyden
Introduction
Jose Van Der Heyden is a notable inventor based in Munte, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic polypeptides. With a total of 3 patents to his name, his work has the potential to impact the treatment of various illnesses.
Latest Patents
One of his latest patents includes the development of chimeric interleukin 5-receptor/immunoglobulin polypeptides. These chimeric polypeptides are encoded by a DNA sequence that contains a first DNA subsequence coding for a fragment of at least one of the alpha- and/or beta-chain of the human interleukin-5 receptor. Additionally, a second DNA subsequence codes for the constant domains of a heavy- or light-chain of a human immunoglobulin, or a fragment thereof. This innovation is particularly useful in treating illnesses with demonstrated eosinophilia.
Career Highlights
Jose Van Der Heyden is currently employed at Hoffmann-La Roche Inc., where he continues to advance his research and development efforts. His work is characterized by a strong focus on therapeutic applications that address critical health issues.
Collaborations
Throughout his career, Jose has collaborated with esteemed colleagues such as Rene Devos and Walter C. Fiers. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Jose Van Der Heyden's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments.